Riskpilot← Back to searchSign inGet full accessCiBiD Group ApS
APSBankruptCVR 38254855Amaliegade 10Manufacture of pharmaceutical preparations · NACE 2120Est. 20161 employees
Revenue 2020
DKK -2,4M
-332% vs 2019
EBITDA margin
121.2%
-649% vs 2019
Equity ratio
-2555.7%
Financial strength
Net profit 2020
DKK -2,9M
-855% vs 2019
| Revenue | DKK -2,4M | -332% |
| EBITDA | DKK -2,9M | -649% |
| Net profit | DKK -2,9M | -855% |
| Total assets | DKK 105K | -93% |
| Equity | DKK -2,7M | -1224% |
| Employees | 1 | — |
Legal name
CiBiD Group ApS
CVR number
38254855
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
12. december 2016
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Amaliegade 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Revenue | 118 | 1.599 | 1.024 | -2.375 |
| Staff expenses | -692 | -1.198 | -499 | -504 |
| EBITDA | -574 | 401 | 525 | -2.879 |
| Depreciation & amort. | -6 | -16 | -34 | -18 |
| EBIT | -579 | 385 | 491 | -2.897 |
| Net financials | -1 | -4 | -37 | -34 |
| Profit before tax | -580 | 381 | 454 | -2.931 |
| Tax | -0 | -0 | 65 | -0 |
| Net profit | -580 | 381 | 388 | -2.931 |
| Item | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Total assets | 516 | 475 | 1.519 | 105 |
| Equity | -530 | -149 | 240 | -2.691 |
| Long-term debt | 0 | 0 | 65 | 0 |
| Short-term debt | 1.047 | 624 | 1.214 | 2.797 |
| Total debt | 1.047 | 624 | 1.280 | 2.797 |
EBITDA margin
-287900900.0%
This company
15.8%
Market median
-1822157695% vs market
20172020
Equity ratio
-2555.7%
This company
38.2%
Market median
-6790% vs market
20172020
Return on equity
-293077100.0%
This company
18.4%
Market median
-1592810426% vs market
20172020
Net profit margin
-293077100.0%
This company
8.1%
Market median
-3618235902% vs market
20172020
Asset turnover
-22.55×
This company
1.12×
Market median
-2113% vs market
20172020
Debt / equity
1.04×
This company
0.62×
Market median
-68% vs market
20172020
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2016-12-12 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KT Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
WIP CAPITAL HOLDING ApS | Company | 50.0% | 50.0% | 2016 |
| Individual | 50.0% | 50.0% | 2016 | |
CiBiD A/S | Company | 100.0% | 100.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CiBiD Group ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kell Thomas | Management | 0 companies |
| Peter Wedel Ranch Krarup | Board of Directors | 0 companies |
| David Hald | Board of Directors | 0 companies |
| Anders Peter Wathne Nielsen | Board of Directors | 0 companies |
| Jens Kristian Kjærgaard | Board of Directors | 0 companies |
| Christian Heslet Jørgensen | Board of Directors | 0 companies |